Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials of New Chemopreventive Agents
Messing, E.
University of Wisconsin Madison, Madison, WI, United States
Search 254 grants from E. Messing
Search grants from University of Wisconsin Madison
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Analytical Core
The Administrative Core
The Fortune Society Ready-to-Respond Project
Integated Treatment Service-Girls (ITS GIRLS) Program
Membrane Binding and Immune Recognition of Colicin E1
Recently added grants:
Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model
Defining the role of cortical circuit dynamics in learning and addiction
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
Brain and Genetic Predictors of Individual Differences in Pain and Placebo Analgesia
Determining Optimal Treatment Intensity for Children with Language Impairment (LI)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025434-001
Application #
2302098
Study Section
Project Start
1993-06-15
Project End
Budget Start
1993-06-15
Budget End
1999-06-15
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Related projects
NIH 1999
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1997
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1996
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1993
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Messing, E. / University of Wisconsin Madison
Publications
Messing, Edward; Kim, Kyung Mann; Sharkey, Francis et al.
(2006)
Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
J Urol 176:500-4
Comments
Be the first to comment on this grant